Hongkui Deng, who has been working on a trial involving iPSC transplants, is observed by students. By the age of 25, Mingyu, a pseudonym being used to protect her privacy, had already undergone two liver transplants and a pancreas transplant in an effort to treat her type 1 diabetes. In her ten years living with
